Long-term follow-up of early stage breast cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter cohort study aims to collect long-term follow-up data from patients diagnosed with early-stage invasive breast cancer who participated in neoadjuvant or adjuvant clinical trials conducted by the GEICAM group. Patients will be monitored for approximately 30 years after completing their original study follow-up. The study seeks to evaluate the long-term efficacy and potential sequelae of treatments, providing valuable insights for healthcare professionals and society. The data collected will enhance understanding of the long-term evolution of early-stage invasive breast cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected.
* Patients whose death or contact loss has not been previously collected in the databases of the original studies.

Exclusion Criteria:

* Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal.

Where it's running

• Hospital San Agustín Avilés
  Avilés, Principality of Asturias, Spain Recruiting
• Centro Oncológico de Galicia
  A Coruña, Spain Recruiting
• Complejo Hospitalario A Coruña
  A Coruña, Spain Recruiting
• Complejo Hospitalario Universitario de Albacete
  Albacete, Spain Recruiting
• Hospital General Universitario de Alicante
  Alicante, Spain Recruiting
• Hospital General Universitario de Elche
  Alicante, Spain Recruiting

+23 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: Study Project Manager
• Email: inicio_ensayos@geicam.org
• Phone: 00346592870

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized breast positioning to speed and improve prone radiotherapy

  This trial tests whether a personalized VENUS SHELL immobilizer helps patients with early breast cancer or DCIS receive precise radiotherapy more comfortably while lying face down.

  Recruiting HeroSupport SA · New York, New York · NCT07711847

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.